| | More

2014 ATS Foundation Partner and Unrestricted Grants

ATS FOUNDATION RESEARCH GRANT APPLICATION INSTRUCTIONS

Applications must be submitted on or before
Wednesday, September 3rd at 11:59 pm EASTERN time

You must have received an email inviting you to submit a full application for all the grants below, EXCEPT the ATS Foundation/Breathe California of Los Angeles Research Grant*, in order for your proposal to be accepted. *All proposals for the ATS Foundation/Breathe California of Los Angeles Research Grant that meet the eligiblity requirements will be accepted for review.

The grants and awards are explained below, along with the application process, applicant qualification requirements, instructions, timeline for the review process and submission requirements.

Please contact Erin Marie Nebel, MA, Senior Manager, ATS Foundation Research Program at emnebel@thoracic.org or 212-315-8696 with any questions related to requirements and eligibility.

2014 Research Program Portfolio

Timeline for 2014 ATS Foundation Grants 
(Funding to begin October 31, 2014)

May 9, 2014 Deadline for submission of letters of intent (LOI); May 23, 2014 for PHA Grants
July 11, 2014 Review of the LOI’s
Mid July 2014 Applicants will receive official notification on their LOI’s
September 3, 2014 Submission deadline for full grant applications 
October 15 and 16, 2014 Review of grant applications
Late October 2014 Award notifications sent to applicants and institutions

Grant Opportunities

ATS Foundation Unrestricted Research Grants

The ATS Foundation will award three (3) unrestricted research grants.  For the first time, the ATS Foundation will offer one unrestricted research award in each of the following categories: pulmonary, sleep, and critical care. Though these unrestricted awards have always been available to sleep and critical care investigators, the majority of applications have focused on pulmonary research. By committing funds to sleep and critical care research, the ATS Foundation is aiming to increase the number of high quality applications received in these areas.

The ATS Foundation encourages international and domestic applications in basic, patient-oriented, and public health topics. In the area of public health, the ATS Foundation is particularly interested in funding projects that will inform health policy decisions. These include projects that explore the quality and safety of a specific treatment and compare the effectiveness of different therapies.

For this year only, funding for these unrestricted grants will be reduced to $40,000 for one year.  Previously awarded research grants will not be affected.

Partner Grants

ATS Foundation/Alpha-1 Foundation Research Grant­ (1 grant available)

  • Co-funded by the ATS Foundation and the Alpha-1 Foundation. Please visit alpha-1foundation.org for more information about our partner.

The target audience for these research grants will be investigators interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1). The focus of the research grants will be programs that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career.  Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the applicant's institution.

Applicants must have completed their primary research training (PhD or sub-specialty fellowship training) by July 1, 2014 and have a firm commitment from their home institution for a faculty position.  The following individuals are not eligible for this award:

  • US-based trainees who do not hold a Visa that spans the project period of the grant
  • Current awardees of the ATS Foundation Research Program
  • Individuals who have received 2 ATS grants

ATS Foundation/American Lung Association of the Mountain Pacific Research Grant (1 grant available)

The ATS Foundation has partnered with the American Lung Association of the Mountain Pacific to fund one grant for $50,000 per year for 2 years. This award is restricted to individuals working at Oregon-based institutions, and investigators must also meet all eligibility criteria listed below.  The ATS Foundation/ALA Mountain Pacific Grants are available for junior researchers investigating lung disease, sleep, and critical care.  Both basic science and patient-oriented research proposals are encouraged.  Patient-oriented research is defined as research performed with human subjects (or on material of human origin such as tissues or other specimen). This area of research includes 1) disease mechanism; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies.  Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two.  Indirect costs will not be paid to the applicant’s institution.

ATS Foundation/Boehringer Ingelheim Pharmaceuticals, Inc. Career Development Award in Idiopathic Pulmonary Fibrosis (1 award available)

  • This activity is supported by a research grant from Boehringer Ingelheim Pharmaceuticals, Inc. Please visit boehringer-ingelheim.com for more information about our partner.

The Fellowship Career Development Award is designed to support the research of a fellow undergoing training in Idiopathic Pulmonary Fibrosis-directed research. Applicants should submit proposals for mentored projects addressing important areas of investigation in Idiopathic Pulmonary Fibrosis. Applicants may request up to $50,000 for one year.

Individuals who already have faculty positions are not eligible. Applicants must be enrolled in an accredited pulmonary/critical care training program and must be in good standing in the program. The goal is to support the research efforts of fellows during the latter part of their training (typically after their second year of training) in order to enhance their educational experience, advance discovery, and promote careers in academia. In line with these goals, applicants must hold a MD, DO, MD/PhD, PhD, DVM, or equivalent degree and should plan to pursue a career in academic medicine.

During the period of this award, applicants may not accept other training awards or other external funds that provide stipend or salary support for the same work outlined in their proposal. Applicants must also be a U.S. citizen or resident alien with a Permanent Resident Card ("Green Card") at the time the application is submitted.  Grant funds may not go towards indirect costs.
In addition, the following individuals are not eligible for this award:

  • US-based trainees who do not hold a Visa that spans the project period of the grant
  • Current awardees of the ATS Foundation Research Program
  • Individuals who have received 2 ATS grants

*For Applicants of the ATS Foundation/Boehringer Ingelheim Pharmaceuticals Career Development Award in Idiopathic Pulmonary Fibrosis Only: No salary or fringe benefit payments may be made from ATS Foundation funds. The granted funds support necessary incremental personnel and other direct costs/fees that are associated with conducting the research. The level of effort required for the research project must be allowed by the employing agency as part of the individuals' official duties.

ATS Foundation/Breathe California of Los Angeles Research Grant (1 award available)

  • Co-funded by the ATS Foundation and Breathe Califonia of Los Angeles. Please visit breathela.org for more information about our partner.
  • THIS GRANT DOES NOT REQUIRE AN INVITATION TO APPLY 

The American Thoracic Society Foundation/ Breathe California of Los Angeles Research Grant invite applications from investigators at any stage in their career who are based in Southern California (south of Bakersfield, CA). This grant program seeks to advance understanding and improve the diagnosis and management of Chronic Obstructive Pulmonary Disease, including but not confined to pathogenesis, pathophysiology, epidemiology, prevention, treatment and management of the disease. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the applicant's institution.

ATS Foundation/Pulmonary Hypertension Association Research Fellowship (1 grant available)

  • Co-funded by the ATS Foundation and the Pulmonary Hypertension Association (PHA). Please visit phassociation.org for more information about our partner.

The target audience for this research fellowship will be investigators interested in research in pulmonary arterial hypertension. The fellowship will be directed to supporting research into the pathophysiology of PAH, toward elucidating mechanistic pathways and identifying novel therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project should have potential applicability to human pulmonary vascular diseases. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. A primary goal of the ATS Foundation and PHA Research Programs is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution. Investigators are also encouraged to connect through PHA's professional network, PH Clinicians and Researchers, during the course of their research. Indirect costs will not be paid to the sponsoring institution.

ATS Foundation/Pulmonary Fibrosis Foundation/Coalition for Pulmonary Fibrosis Research Grant (1 grant available)

  • Co-funded by the ATS Foundation, the Coalition for Pulmonary Fibrosis, and the Pulmonary Fibrosis Foundation. Please visit coalitionforpf.org and pulmonaryfibrosis.org for more information about our partners.

The target audience for these research grants will be domestic and international investigators interested in research that is relevant to pulmonary fibrosis. The focus of the research grant will be programs that have a high likelihood to advance the understanding of pulmonary fibrosis. Applications are encouraged from new faculty members who have a strong link with one or more senior investigator. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the applicant's institution.

ATS Foundation/Scleroderma Foundation Research Grant­ (1 grant available)

  • Co-funded by the ATS Foundation and the Scleroderma Foundation. Please visit scleroderma.org for more information about our partner.

The target audience for these research grants will be investigators interested in research that is directly relevant to lung disease that results from scleroderma (ie, systemic sclerosis or SSc). The focus of the research grants will be programs that have a high likelihood to advance the understanding of scleroderma-associated lung disease. Applications are encouraged from new faculty members who have a strong link with one or more senior investigator. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution.

ATS Foundation Tobacco-Dependence Research Fund Grant: For Research on Basic Mechanisms Involved in Tobacco Dependence (1 grant available)

  • Made possible by a generous grant from the ATS Foundation Tobacco-Dependence Research Fund.

The grant will be targeted for research on basic mechanisms involved in tobacco dependence, including such areas as neurogenetics, pharmacology, neuropharmacology, cell receptors, airway sensory responses, and other basic science areas that enhance understanding of the basic mechanisms causing tobacco dependence.  This grant is NOT intended to support studies that examine the adverse consequences of cigarette smoking. The Principal Investigator must be a member of a division of pulmonary and critical care medicine. Trans-disciplinary, cross-department collaboration is encouraged. Preference will be given to projects that, because of their novelty, require bridge funding before becoming competitive for other funding mechanisms. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Applicants must meet the criteria listed below. A primary goal of the ATS Foundation Research Program is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. At least one of the senior investigators must also be a member of the applicant's pulmonary and critical care medicine division. Both US and non-US based investigators are encouraged to apply. At least one of the investigators must be an ATS member at the time of application, and the principal investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution.

Applications are due on September 3, 2014 by 11:59 PM EASTERN time.

ELIGIBILITY AND GUIDELINES

lease read the eligibility information below before you start your application. If you have any questions, please contact Erin Marie Nebel, MA, Senior Manager of the ATS Foundation Research Program, at emnebel@thoracic.org

The ATS Foundation/Alpha-1 Foundation Research Grant and the ATS Foundation/Boehringer Ingelheim Pharmaceuticals, Inc. Career Development Award in Idiopathic Pulmonary Fibrosis award have different eligibility criteria than the other ATS Foundation partner and unrestricted grants. These criteria are listed in the description for these awards posted above. Applicants for these grants should disregard the guidelines that follow.

A primary goal of the ATS Foundation Research Program is to enable new investigators the chance to make the transition to careers as established investigators. Applicants must have completed their primary research training (PhD or sub-specialty fellowship training) by July 1, 2014 and have a firm commitment from their home institution for a faculty position. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their research training. At least one of the key personnel must be an ATS member at the time of application, and the principal investigator must be an ATS member at the time that the grant is awarded. Individuals may submit multiple letter of intent (LOI) applications, but ATS will extend at most one invitation to submit a full grant application to each applicant. Consistent with our intention to support early career investigators, applicants shall not be over 12 years beyond their doctoral degree or equivalent (i.e., MD, PhD, DVM).

Applicants shall not be the recipients of relatively large national awards defined as an NIH R01, Veterans Affairs Grant, Department of Defense Grant or equivalent awards with funding of ≥ $100,000 per year for at least 2 years from a single independent (nonmentored) grant at any time.

Investigators who hold active career development grants (such as K award from the NIH) are eligible to receive ATS research funding, but the ATS project should differ scientifically from the already funded award.
At the present time, investigators in the following categories are not eligible to apply for ATS grants:

  • US-based trainees who do not hold a Visa that spans the project period of the grant
  • Current awardees of the ATS Foundation Research Program
  • Individuals who have received 2 ATS grants

REVIEW PROCESS

The ATS Scientific Advisory Committee (SAC) will review the applications on October 15 and 16. The membership of the SAC is listed on the ATS Website. Additional ad hoc reviewers, especially in the areas of sleep and critical care, will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program. Funding will begin on October 31, 2014.

ATS POLICY ON ADDITIONAL GRANT FUNDING

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the ATS within one month of formal notification of award. A subcommittee of SAC will assess degree of overlap. In case of significant scientific overlap the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed.

INSTRUCTIONS FOR APPLYING

Application forms are available on the Foundant Technologies website.

You must use the same login credentials that you used to submit the letter of intent.

Please note that after you submit your application it will be reviewed by ATS staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

KEY PERSONNEL

Please a) list the key personnel on your project b) list each of their roles on the project (mentor, consultant, research technician, etc.) c) approximate the total percentage of total effort that the person will contribute to the project.

SYNOPSIS

USING TERMS THAT CAN BE UNDERSTOOD BY A NON-SCIENTIFIC AUDIENCE, please briefly describe what you are investigating, the techniques you will use to support your hypothesis, and how your project will contribute to scientific understanding of your disease of interest.

Note that this General Audience Summary will become public information; therefore, do not include proprietary/confidential information.

PATIENT SUMMARY

Please explain how your research may lead to improved patient outcomes.  A patient advocate may help review and vote on your application.

SAC REVIEWERS SUMMARY

Please provide a technical abstract of your proposal, keeping your response to 5000 characters or less.

FUTURE PLANS

Where would you take this research after funding ends, and how will this support contribute to your research career development?

LAB RESOURCES AND EQUIPMENT

List the resources that you have available to you that will be needed to complete your project.  Describe these resources, and explain how each will contribute to the successful completion of your project.  Please note that the limit for this section is two pages.

This document should be divided into seven sections:

  • Laboratory
  • Clinical
  • Animal
  • Computer
  • Office
  • Major Equipment
  • Other

    LITERATURE CITED

    • No page limit
    • List citations by number in the order in which they appear in the text.
    • Use the following format shown below (“New England Journal of Medicine” style in EndNote and “Annals of Internal Medicine” in Reference Manager).
    1. Kajikawa O, Frevert CW, Lin SM, Goodman RB, Mongovin SM, Wong V, Ballman K, Daubeuf B, Elson G, Martin TR. Gene expression of toll-like receptor-2, toll-like receptor-4 and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia. Gene 2005;3:193-202.
    2. Altemeier WA, Matute-Bello G, Frevert CW, Kawata Y, Kajikawa O, Martin TR, Glenny RW. Mechanical ventilation with moderate tidal volumes synergistically increases lung cytokine response to systemic endotoxin. Am J Physiol Lung Cell Mol Physiol 2004;164:1949-1958.

    RESEARCH PLANS (10 page limit)

    PLEASE CHECK: The Research Plan (Sections A-D) must be no longer than 10 pages including pictures with margins at .75 (right and left), .50 (top and bottom), using Arial size 11 font with no less than single-line spacing.

    The Research Plan should include sufficient information needed for evaluation of the project. The format for preparing this section is provided below. Be specific and informative, and avoid redundancies. 

    A. STATEMENT OF PROBLEM AND SPECIFIC AIMS

    What do you intend to do?

    State the problem concisely and describe the specific aims of the research proposal. What is the hypothesis you will test? What is the experimental paradigm?

    B. BACKGROUND AND SIGNIFICANCE

    Why is the work important?

    Briefly provide the scientific background leading to the present application. Critically evaluate existing knowledge and identify the scientific gaps that the project is intended to fill. If the aims of the proposal are accomplished, how will this affect the scientific field? Where will these studies lead in developing a larger research program?

    C. WORK ACCOMPLISHED AND PRELIMINARY STUDIES

    What has already been done?

    Provide an account of the principal investigator’s preliminary studies pertinent to this application. Preliminary data often aid the reviewers in assessing the likelihood of the success of the proposed project. List any publications, manuscripts accepted for publication, patents, or other printed materials that have resulted from preliminary studies.

    D. RESEARCH DESIGN AND METHODS

    How are you going to do the work?

    Describe the research design and methods that you will use in the proposed studies. Organize this section by the specific aims of the research proposal. Include how the data will be collected, and analyzed, and describe potential problems or limitations. Published or commonly used methods do not need to be described in detail. This section must be written so that reviewers can evaluate the scientific questions, the experimental design, and the likelihood that the experiments will produce interpretable results. Include a tentative timetable showing how you will prioritize the work. Clearly identify collaborations with other investigators at the same or other institutions.

    LETTERS OF RECOMMENDATIONS

    You are responsible for providing and uploading two (2) reference letters (letters of support). These must be uploaded before you can submit your application. Letters sent directly to the ATS office will NOT be accepted.  Letters of support are usually just that - letters from someone not involved in the project but who can emphasize its importance. Similarly, institutional leaders (e.g., division director, chair, dean) can write letters to highlight their commitment for the candidate.  A mentor could also be included here.  You need to determine the best people to write these letters of support considering that they are included to enhance your application.

    Please place all letters of support into a SINGLE ZIP file and upload this file to your application.

    LETTER FROM COLLABORATOR

    You may also submit letter(s) from collaborator(s) or donor(s) who are providing expertise or reagents needed to accomplish the work. You may submit as many of these letters as you feel are necessary.  Please place all letters from collaborators into a SINGLE ZIP filed and upload this file to your application.

    BIOSKETCHES

    Please note that you MUST observe the limits indicated in the biosketch template (For example, publications must end on page 2). Applications with biosketches that do not meet the requirements will be un-submitted.  Biosketch templates should be downloaded from here.

    RESUBMISSION STATEMENT (2 page limit)

    A resubmission is an application that was reviewed in a previous cycle, but was not funded.  Please note that an application is not considered a resubmission if it has major changes.  Only fill out and upload this form if your application is a resubmission.

    In the Resubmission Statement you must:

    1. Explain how you addressed the scientific critiques of the original application
    2. Explain how the application has been strengthened and modified since the original submission. 

    DISCLOSURE OF CONFLICT OF INTERESTS

    Many individuals have competing interests that may cause conflicts of interest. Disclosure and review of a potential "conflict of interest" (COI) that might affect an ATS research award doesn't imply that an "outside interest", or a person with such a relationship or interest, is wrong or inappropriate. Nor does it imply criticism of the character or actions of the individual, or of any commercial or non-commercial entities with which an individual may be involved. Rather, ATS COI policies and procedures exist to assure the public of appropriate levels of transparency of the outside interests of participants in official ATS activities, and that official ATS activities are managed in a manner that maintains scientific rigor and independence.

    • Disclosure of a real or potential COI will not automatically invalidate an application.

    All personal financial relationships with commercial entities (such as pharmaceutical companies and medical device manufacturers), and/or with non-commercial, non-governmental funders (such as private foundations), that are relevant to the application’s subject matter must be disclosed. Such involvement with relevant commercial entities (companies) includes employment or ownership; consultancy(ies); Board or advisory committee service; service on speakers' bureaus or other acceptance of lecture fees directly paid by the company; expert testimony on behalf of the company; research grants; patents received or pending; royalties; and stock ownership or options (excluding mutual funds unless a sector fund concentrated in an industry or industries relevant to the activity).

    The ATS "Policy on Tobacco Relationships" requires that individuals with a current tobacco industry relationship not hold certain ATS roles, including that of research awardee. (Note: if the relationship is limited to personal holdings of tobacco stocks or options, divestiture of such holdings. See the policy for details.)

    PLEASE RESPOND in the corresponding answer spaces on the online application.

    COI 1A: Have you within the past 12 months had a financial interest in a commercial entity (i.e., a “commercial interest”) that could be considered broadly relevant to the subject matter of this proposal, or do you expect to have one during the duration of the grant award period?

    COI 1B: If yes, please provide the company name(s) and the type of relationship:

    COI 2A: Have you within the past 12 months received financial support from a non-commercial, non-governmental source (such as a private foundation or other non-profit source) that could be perceived as a real or potential conflict of interest relevant to the subject matter of this proposal, and/or do you expect to receive such before the end of the grant award period?

    COI 2B: If yes, please provide the organization name(s) and the type of relationship:

    COI 3A: Have you within the past 12 months had any non-financial affiliation or interest (i.e., a personal, professional or other affiliation or interest) that might be perceived to be a real or potential conflict of interest relevant to the subject matter of this proposal, and/or do you expect to receive such before the end of the grant award period?

    COI 3B: If yes, please provide the company or organization name(s) and the type of relationship:

    COI 4A: Have you within the past 12 months had a professional relationship with a tobacco entity or expect to have one before the end of the grant award period?

    COI 4B: If yes, please provide the company or organization name(s) and the type of relationship:

    SIGNATURE PAGE

    After you complete all of the proposal sections, you must print the signature page available here, sign it and have your financial administrator sign it. Then, upload the signed page back onto the application as an attachment. Please only upload one signed page. Please do NOT mail the signature page to the ATS office.

    BUDGET FORM

    Click here to complete the budget form.

    Please contact Erin Marie Nebel, MA at emnebel@thoracic.org with any questions.